Sigalit Ariely-Portnoy, Ph.D

CEO

Dr. Ariely-Portnoy has many years of experience in the pharmaceutical industry (15 years at Taro and Teva and 9 years at Gsap) and is very well acquainted with pharmaceutical processes, change management processes, and building of production plants. Her role in Taro was SVP for operations in Israel and in Teva, it was OSD plant manager, responsible for more than 1,000 worker production of sales of 2.4B $per year.

Dr. Ariely-Portnoy served as President of the Israeli Chapter of Parenteral Drug Association (PDA) from 2003 to 2006.

In 2009, Dr. Ariely-Portnoy founded Gsap, which provides regulatory, clinical, quality, and validation services to pharmaceutical, biotechnology Cell therapy, and medical device companies as well as hospitals. As part of her vast experience, she has successfully led hundreds of regulatory audits by the Israeli MoH, the FDA, the EMA, and various Notified Bodies. Under her management, Gsap executed dozens of Regulatory submissions for innovative drugs and devices.

Sigalit's s nature is the force that brings Gsap entire staff to lead processes in cooperation with the clients to achieve their goals.